Covalon Technologies Ltd. (CVE:COV – Get Free Report) shares were up 1.8% on Friday . The company traded as high as C$2.24 and last traded at C$2.24. Approximately 621 shares traded hands during mid-day trading, a decline of 95% from the average daily volume of 11,504 shares. The stock had previously closed at C$2.20.
Covalon Technologies Stock Up 1.8%
The company has a debt-to-equity ratio of 6.33, a quick ratio of 6.45 and a current ratio of 7.57. The firm has a fifty day simple moving average of C$2.16 and a 200-day simple moving average of C$1.92. The firm has a market cap of C$61.86 million, a price-to-earnings ratio of 44.80 and a beta of 1.22.
About Covalon Technologies
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.
See Also
- Five stocks we like better than Covalon Technologies
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Receive News & Ratings for Covalon Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covalon Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
